Mirati Therapeutics reported $-135680000 in Pre-Tax Profit for its first fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Pre Tax Profit Change
Acceleron Pharma XLRN:US $ -63.51M 0.05M
Agios Pharmaceuticals AGIO:US $ -82.79M 8.09M
Alnylam Pharmaceuticals ALNY:US $ -188.33M 10.94M
Astellas Pharma 4503:JP Y 35830M 54733M
Bayer BAYN:GR € 1537M 1825M
Bluebird Bio BLUE:US $ -231.42M 25.67M
Eisai 4523:JP Y 55783M 61588M
Eli Lilly And LLY:US $ 1988.6M 80.6M
Exelixis EXEL:US $ 124.89M 126.9M
GlaxoSmithKline GSK:LN 1482M 225M
IONIS PHARMACEUT IONS:US $ -81M 8.74M
Johnson & Johnson JNJ:US $ 7776M 515M
Moderna Inc MRNA:US 3.06B 1.8B
Nektar Therapeutics NKTR:US $ -125.16M 3.89M
Novartis NOVN:VX SF 4424M 620M
Sarepta Therapeutics SRPT:US $ -81.76M 85.63M
Spectrum Pharmaceuticals SPPI:US $ -49.92M 14.24M
Ultragenyx Pharmaceutical RARE:US $ -121.96M 13.8M
YTE INCY:US $ 199.6M 31.06M